ScienCare Pharma’s Naltrexone Implant Prioritized for Review by CDE
The Center for Drug Evaluation (CDE) website indicates that the market filing by China-based Shenzhen...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity
The Center for Drug Evaluation (CDE) website indicates that the market filing by China-based Shenzhen...